Share this article

Development of best clinical practice guidelines for epidermolysis bullosa

Elizabeth Pillay, Jane Clapham
10 December 2018

Epidermolysis bullosa (EB) is a rare genetic skin fragility disorder and the majority of patients live with life-long wounding. EB is not specific to any racial group and those affected by the disorder can be found all over the world. In contrast with many other countries, the UK is fortunate to have well-developed specialist services with experienced multidisciplinary teams who serve this patient group. Sharing of experience and expertise is particularly crucial in caring for those with rare conditions and this recognition led to the development of guidelines to be shared globally. In 2012 and, more recently, in 2016, London EB centres led on the development of best practice guidelines for skin and wound care in EB, with participation from EB professionals worldwide, patients and carers. This article outlines the process of developing the guidelines and the challenges of finding evidence to support management strategies in a complex rare condition.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.